Adocia
Phase 3Adocia is a clinical-stage biotechnology company specialized in the development of innovative treatments for diabetes and obesity.
Founded
2005
Focus
AntibodiesBiologicsDrug Delivery
About
Adocia is a clinical-stage biotechnology company specialized in the development of innovative treatments for diabetes and obesity.
Funding History
7Total raised: $155M
Debt$15MEuropean Investment BankJun 15, 2021
Grant$5MBPI FranceJun 15, 2018
IPO$40MEuronext ParisApr 3, 2014
IPO$40MUndisclosedMar 20, 2014
Company Info
TypePrivate
Founded2005
LocationLyon, France
StagePhase 3
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile